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ABSTRACT 
Hematopoietic stem cells (HSC) from cord blood are potentially high sources for transplantation due to their low 
immunogenicity and the presence of the multipotent cells. These cells are capable of differentiating to produce 
various lineages of blood cells under specific conditions. We have enriched highly purified CD34+ cells from 
cord blood, determined in vitro growth of the cells in culture systems in the absence (condition A) or presence of 
GM-CSF and G-CSF (condition B), and determined the profile of immune cells during the period of cultivation 
by using flow cytometry. PhytohemagglutininA (PHA) was used as a mitogen to stimulate T lymphocytes de-
rived from hematopoietic stem cells. GM-CSF and G-CSF prolonged the survival of the growing cells and also 
maintained expansion of cells in blastic stage. By day 12 of cultivation, when cell numbers peaked, various types 
of immune cells had appeared (CD14+ cells, CD40+HLA-DR+ cells, CD3+CD56+ cells, CD19+ cells, CD3+CD4+ 
cells, CD3+CD8+cells and CD3-CD56+). A significantly higher percentage of monocytes (p = 0.002) were ob-
served under culture with GM-CSF, G-CSF when compared with culture without GM-CSF, G-CSF. In addition, 
T lymphocytes derived from HSC responded to 50 µg/ml of PHA. This is the first report showing the complete 
differentiation and proliferation of immune cells derived from CD34+ HSC under in vitro culture conditions. 
Lymphocytes, monocytes, dendritic cells and polymorph nuclear cells derived from HSC in vitro are unique, and 
thus may benefit various studies such as innate immunity and pathophysiology of immune disorders. 
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INTRODUCTION 
HSC derived from umbilical cord blood 
have the potential for use in transplantation 
due to their low immunogenicity. These plu-
ripotent cells are capable of differentiation to 
produce various lineages of blood cells under 
specific conditions (Newcomb et al., 2007) 
and CD34+ HSC can be driven to become 
either lymphoid or myeloid cells in vitro 
(Huang and Terstappen, 1994). Blood cells 
such as neutrophils and platelets derived 
from in vitro differentiated HSC have been 
investigated for use in cellular immunother-
apy (Timmins et al., 2009; Chen et al., 
2009). However, in vitro development of 
lymphoid lineages and the immune functions 
of these cells have only rarely been explored. 
Hematopoietic growth factors i.e. stem 
cell factor (SCF) (Hassan and Zander, 1996), 
IL-3 (Bryder and Jacobsen, 2000), and colo-
ny-stimulating factor (CSF) (Bociek and 
Armitage, 1996; Clark and Kamen, 1987), 
are crucial stimulators that drive the differen-
tiation of HSC to various cell types 
(Kaushansky, 2006). The multiple benefits 
for each of these hematopoietic growth fac-
tors have been well characterized and in vitro 
analysis has revealed synergistic effects of 
SCF, IL-1, IL3 and IL-6 on hematopoietic 
progenitor cells (Leary et al., 1988; Duarte 
and Frank, 2000). 
Generally, in vitro analysis of cellular 
immune responses to antigens employs pe-
ripheral blood mononuclear cells (PBMC); 
in vitro vaccine testing also relies on PBMC 
activation and proliferation (Castle, 1994). 
However, cells that are exposed to antigens 
in the human body are not only the circulat-
ing immune competent cells but also the 
newly differentiated and young progenitor 
cells that are found in bone marrow and may 
not be in peripheral blood. Evidence support-
ing the ability of progenitor cells to respond 
to signals comes from the presence of Toll-
like receptors and their co-stimulatory mole-
cules on the multi-potential HSC (Nagai et 
al., 2006). For the antigen-experienced adult, 
memory Tcells (CD45RO+) comprise around 
50 % of T cells in peripheral blood with the 
proportion increasing with age to approxi-
mately 80 % of circulating T cells in cente-
narians (Cossarizza et al., 1996). Based on 
these findings naïve T lymphocytes are rela-
tively rare in peripheral blood and how these 
newly differentiated T lymphocytes respond 
to antigenic stimulation is not known. 
This study characterizes the phenotypes 
and functions of various immune cells gen-
erated from the in vitro differentiation of 
CD34+ HSC as well as the phenotypic pro-
files of cell proliferation Moreover, mitogen-
ic responsiveness of the HSC-derived T 
lymphocytes from CD34+ cells are also 
compared and discussed. 
 
MATERIALS AND METHODS 
Purification of cord blood CD34+ cells 
Umbilical cord blood was obtained from 
mothers at normal full-term delivery with 
informed consent. Cord blood was collected 
in the sterile blood collection bags contain-
ing 30 ml of citrate phosphate dextrose (Ka-
wasumi Laboratories, Thailand, Co., LTD) 
as an anticoagulant, and processed within 
4 h. Mononuclear cells (MNCs) were sepa-
rated by density gradient centrifugation 
(1,200 g for 20 min at 20 °C) using Lym-
phoPrep™ (Axis-Shield PoC AS, Oslo, 
Norway). The mononuclear cell fraction was 
collected and washed twice with cool PBS 
containing 2mM EDTA. A CD34 isolation 
kit utilizing the Mini-MACS magnetic mi-
crobead selection (Miltenyi Biotech, Germa-
ny) was used to enrich CD34+ cells from the 
MNCs population. The isolated CD34+ cells 
were serially passed through two Mini-
MACS columns to increase the purity of 
CD34+ cells and eliminate contaminating 
mature cells. The purity of isolated CD34+ 
HSC was determined by flow cytometry and 
viability of the cells was measured using try-
pan blue exclusion dye staining. 
 
In vitro cultivation of HSC 
To observe the effect of GM-CSF and G-
CSF on the proliferation and differentiation 
of purified CD34+ HSC, cells were cultured 
at a density of 1x106 cells/ml using 12-well 
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tissue culture plates in two different condi-
tions (A and B). Condition A consisted of 
Stem line II serum-free hematopoietic stem 
cell expansion medium (Sigma-Aldrich Cor-
poration, Missouri, USA) supplemented with 
50 ng/ml stem cell factor (SCF) (PeproTech, 
Rocky Hill, NJ, USA) , 10 ng/ml IL-3 (R&D 
Systems, Inc., MN, USA), 100 μg/ml trans-
ferrin (Sigma-Aldrich) and 100 μg/ml Hu-
mulin® (Lilly Pharma, Giessen, Germany). 
Condition B was identical to condition A ex-
cept for the addition of 10 ng/ml GM-CSF 
and 10 ng/ml G-CSF (PeproTech, Rocky 
Hill, NJ, USA). Cells were cultured at 37 °C 
in a humidified atmosphere with 5 % CO2. 
On days 4, 8, 12, 16, and 20 of cultivation, 
the phenotypes of the cells were determined 
by flow cytometry using various monoclonal 
antibodies. Half of the medium was replaced 
every 4 days and viability was checked every 
four days with trypan blue exclusion dye 
staining.  
 
Morphological examination 
Cells from cultures were stained with 
Giemsa dye for determining morphology at 
12, 16, 20 and 24 days after cultivation. 5-10 
x 104 cells in 200 μl of medium were spun 
onto a slide by cytospin (Cytospin3, Thermo 
Shandon, UK.), at 400 g for 10 min, and then 
fixed with 95 % ethanol for 10 min. Thereaf-
ter, cells were stained for 10 min with Giem-
sa diluted with PBS (ratio 1:4 by volume), 
and washed with tap water. Stained slides 
were dried at room temperature and the cell 
morphology was observed under a light mi-
croscope. Approximately 300 cells per slide 
were scored. 
 
Flow cytometric analysis 
The immune phenotypes of cells were 
determined by flow cytometry to monitor the 
level of HSC differentiation and the presence 
of various cell types. Mononuclear cells (1 x 
105 cells) from each culture condition were 
stained with the fluorescent dye-labeled 
monoclonal antibodies and incubated for 30 
minutes at 4 °C in the dark. The cells were 
then washed twice with PBS by centrifuga-
tion at 800 g, 5 min at 4 °C and fixed with 
1 % paraformaldehyde in PBS. The stained 
cells were analyzed by FACScan flow cy-
tometry (Beckman Coulter, USA) to deter-
mine the expression pattern of lineage-
associated antigens that indicate the various 
committed cellular subsets using a commer-
cially available kit with fluorochrome-
labelled monoclonal antibodies [(Biolegend): 
CD34+HLA-DR-, CD3+CD4+, CD3+CD8+, 
CD19+, CD14+, CD56+CD3-, CD56+CD3+, 
CD40+HLA-DR+]. 
 
Lymphocyte proliferation assay 
In order to confirm the responsiveness of 
the lymphocytes derived from the cultivated 
hematopoietic stem cells, the CD34+ HSC 
were expanded under conditions A or B for 
10 days in order to obtain a sufficient quanti-
ty of cells for the study. Mononuclear cells 
(2 x 105 cells) were suspended in 100 µl of 
the culture medium in duplicate wells of 96-
well tissue culture plates (Corning Incorpo-
rated Costar®, NY, USA). The cells were co-
cultured with 100 µl PHA at a final concen-
tration of 2, 10, 50 µg/ml, or without PHA. 
PBMC from 7 healthy donors were isolated 
according to the protocol previously pub-
lished by Le and colleagues (2006) and also 
assayed to compare the level of PHA stimu-
lation. Plates were incubated in a 5 % CO2 
humidified atmosphere at 37 °C. Cells were 
harvested on days 2, 4 and 6 of cultivation, 
washed with PBS, counted viable cells by 
trypan blue exclusion dye staining. The re-
sults were expressed as the mean of dupli-
cate wells and compared with that of control 
cells cultured without PHA. 
 
Statistical analysis 
Data were obtained from 7 different oc-
casions and analyzed using the SPSS pro-
gram (version 11.0, Chicago, USA) and re-
sults were reported as the means ± SD. 
Comparisons were analyzed by the nonpar-
ametric Mann–Whitney U test to evaluate 
statistical significance; p < 0.05 was consid-
ered significant. 
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RESULTS 
Isolation and cultivation of CD34+ HSC  
The amounts of CD34+ cells isolated 
from cord blood ranged from 5 x 105 to 1.1 x 
106 cells. Purity of CD34+ cells isolated from 
cord blood mononuclear cells was between 
95 and 97 %. In the CD34+-enriched MNCs, 
no differentiated cells were observed upon 
staining with a wide range of markers for 
mature immune cells, i.e. CD3, CD4, CD8, 
CD14, CD19, CD40, and CD56. These cells 
were cultured with HSC complete medium 
alone (A condition) or with the addition of 
GM-CSF and G-CSF (B condition) for 40 
days. Growth of the cells is shown in Figure 
1. Total nucleated cells (TNC) had increased 
10-fold on day 4 and 70-fold on day 8, and 
102-fold on day 12 after cultivation in condi-
tion A and 93-fold on day 12 (day of peak) 
in B conditions. The number of cells present 
on days 16, 20 and 24 under B condition was 
significantly higher than that under A condi-
tion (p = 0.02). These results demonstrated 
that the total nucleated cells were significant-
ly increased in the presence of GM-CSF and 
G-CSF (B condition). 
 
Morphological examination by microscopy 
In this study, three cellular lineages were 
assessed:  granulocytic, monocytic, and lym-
phocytic lineages as shown in Table 1. There 
was no significant difference observed of 
thegranulocyte nor lymphocyte in those two 
culture conditions. In B condition (day 12), 
blast cells were significantly higher than that 
A condition (p = 0.02). The numbers of cells 
in blastic stage were dramatically reduced on 
day 16 in both culture conditions and were 
reduced further to undetectable levels by day 
20. The numbers of monocytes on days 16, 
20 and 24 under B condition were signifi-
cantly higher than those under A condition 
(p = 0.02). These results indicate that B con-
dition promoted the differentiation of mono-
cytes. 
 
Cell viability 
The viability of the cultured cells on day 
8 was 100 % in both conditions as shown in 
Figure 2. Viability of the cells started to de-
cline after day 8. TNC reduced by 19 % and 
12 % in on day 12 in A and B condition, re-
spectively, as shown trypan blue exclusion. 
The viability of cells present on days 16, 20, 
24 and 28 under B condition were signifi-
cantly higher than that under A condition 
(p = 0.02). By day 40, most cells were dead; 
the number of viable cells remaining was 3.2 
x 105± 2 x 104and 6 x 105 ± 1.5 x 104 cells in 
A and B condition, respectively.  
 
 
 
Figure 1: Total nucleated cells expanded from 
highly purified CD34+ cells under two different 
conditioned media 
CD34+ cells were cultured in two different media with and 
without cytokine supplement. Viable cells were counted by 
trypan blue exclusion method every 4 days after start of culti-
vation. The data obtained from 7 cord bloods, columns are 
mean values and bars represent SD. * p < 0.05 
 
 
 
Figure 2: Viability of the growing cells (percent-
age) derived from hematopoietic stem cells un-
der in vitro development 
Viability of the cultured cells was determined by trypan blue 
exclusion dye. The data obtained from 7 cord bloods, col-
umns are mean values and bars represent SD. * p < 0.05 
condition A () = SCF, IL-3, Transferin and Humulin; 
condition B () = A + GM-CSF and G-CSF 
condition A () = SCF, IL-3, Transferin and Humulin;  
condition B () = A + GM-CSF and G-CSF 
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Phenotypic profiles of the immune cells 
among total mononuclear cells derived 
from HSC 
Flow cytometry and various monoclonal 
antibodies were used to characterize the phe-
notype upon differentiation of mononuclear 
cells obtained in A and B conditions. At the 
first culture time point assessed (day 4, Fig-
ure 3). MNC in vitro differentiation into 
CD14+ cells and CD40+HLA-DR+ cells was 
observed. On day 8, the highest phenotype 
was CD19+ cells in both culture conditions. 
The CD19+ cells population appeared as 
highest number through day 20 of A condi-
tion, whereas in B condition the CD14+ cells 
population was the highest at days 16 and 
20. 
Comparison between the levels of im-
mune cells obtained from these culture con-
ditions and those in the peripheral blood 
(PB) are shown in Table 2. Monocytes and 
NKcells from the in vitro differentiation 
were similar to those levels in vivo as report-
ed from the PB; T lymphocytes and DC were 
lower than those levels in PB (2.5-fold and 
2.9-fold, respectively), whereas B cells and 
NKT cells were higher than those in PB (3.4-
fold and 3.7-fold, respectively). In B condi-
tion, number of CD14+ cells was higher than 
that in A condition and the cultivated cells of 
A and B condition gave a higher number of 
CD14+ cells than that in PB. 
 
3a  
 
3b
 
Figure 3: Evolution of phenotypic profiles of the immune cells among total mononuclear cells derived 
from HSC. 
Various immune cell types were observed in 2 different culture conditions (3a = condition A and 3b= condition B) in each time 
point during cultivation period by using flow cytometry. Data obtained from 7 cord bloods are mean with S.D., * =p< 0.05 
 = CD3+CD4+, = CD3+CD8+, = CD14+,  = CD19+, =CD3-CD56+, ∆ = CD3+CD56+ and  =CD40+HLA-DR+ 
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Table 1: Morphological examination of HSC cultivation in two different culture conditions 
Condition Cell type (%) Day 12 Day 16 Day 20 Day 24 
A 
Granulocyte 46.3 54.3 59.1 54.5 
Monocytes 19 18 17 20 
Lymphocytes 25.3 26.4 23.9 25.5 
Blast cells 9.4 1.3 NS NS 
B 
Granulocytes 43.5 50.9 56.5 50.7 
Monocytes 18.7 24* 23.5* 26.3* 
Lymphocytes 23.5 24 20 23 
Blast cells 14.3* 1.1 NS NS 
Results represent mean% from 7 cord blood samples. (NS = not seen, * p< 0.05) 
 
 
Table 2: Comparison between HSC-derived mononuclear cells (day 12) under in vitro culture condi-
tions with those in peripheral blood 
Cell Phenotype 
Range (means% ± SD)a 
Reference valuesb 
% Fold Fold 
(A) (B) (A) (B) 
T cells 
8.5-10.7 7.7-10.1 23.9 2.5 2.7 
CD3+ (9.6 ± 1.1) (8.9 ± 1.2) 
6.12-10.4 6.22-10.64 3.5-19.7 1.4 1.8 
CD3+CD4+ (8.26 ± 2.14) (8.43 ± 2.21) 
1.95-2.09 1.99-2.17 3.5–13.4 6.6 6.4 
CD3+CD8+ (2.02 ± 0.07) (2.08 ± 0.09) 
CD4+/CD8+ ratio 4.1 4.05 2 - - 
B cells 9.02-17.14 6.99-15.41 3.4 1.8 
CD19+ (13.08 ± 4.06) (11.2 ± 4.21) 3.9 
Monocytes 5.9-8.3 8.7-10.5 1.1 1.1 
CD14+ (7.1 ± 1.2) (9.6 ± 0.9) 0-8 
NK cells 3.06-7.02 3.67-6.07 1.2 1.2 
CD56+CD3- (5.04 ± 1.98 (4.87 ± 1.2) 4.2 
NKT cells 4.7-5.25 4.73-5.77 3.7 4 
CD56+CD3+ (4.86 ± 0.39) (5.25 ± 0.52) 0–1.3 
DC cells 7.72-8.62 8.24-8.82 2.9 2.8 
CD40+HLA-DR+ (8.17 ± 0.45) (8.53 ± 0.29) 23.7 
The percentage of HSC-derived MNCs on day 12 of cultivation was compared with those reference values in peripheral blood 
(PB). The data obtained from 7 cord bloods and presented as range (means % ± SD).a = data from cultivated cells, b = data from 
level in the blood (Jiang et al., 2004; Klose et al., 2007; Szabolcs et al., 2003), A = condition A, B = condition B. Fold = fold dif-
ferences obtained by calculation when compared the level of each cultivated cell type with the same type of cell in the blood. 
 
 
Responsiveness of HSC-derived MNCs and 
PBMC in response to mitogen 
To evaluate mitogenic response, PHA was used 
to stimulate HSC-derived MNCs after 12 days of 
culture. The MNCs responded well to PHA as 
shown in Figure 4. The level of proliferation index 
upon stimulation of PBMC and HSC-derived 
MNCs with PHA were similar.  
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Figure 4: Proliferation indexes of the PBMC and 
HSC-derived mononuclear cells upon stimulation 
with PHA. 
The total numbers of viable nucleated cells in the cultures 
were measured by trypan blue exclusion on day 4 of the 
cultivation. Data obtained from 7 cord bloods 
 
 
However, this response of HSC-derived 
MNCs was based on stimulation with 50 µg/ 
ml PHA while only 2 µg/ml PHA was used 
for PBMC. 
 
DISCUSSION 
In the present study we enriched and 
highly purified CD34+ cells from umbilical 
cord blood and characterized various cell 
types of the immune system formed during 
the in vitro cultivation. The major goal of 
our study was to determine the patterns of 
cell proliferation and differentiation in the 
presence or absence of GM-CSF and G-CSF. 
These two cytokines are central to hemato-
poiesis, and the modulation of functional re-
sponses, as well as the maintenance of ho-
meostasis and overall immune competence 
(Möhle and Kanz, 2007).  
SCF, IL-3, transferin and humulin were 
used to enhance the proliferation, differentia-
tion, and survival of hematopoietic cells. 
These cytokines are critical for an adequate 
expansion and development of the hemato-
logic lineages (Duarte and Frank, 2000). Our 
study demonstrated that the total nucleated 
cells in the presence of GM-CSF and G-CSF 
were elevated and exhibited enhanced sur-
vival compared with cells in condition A. In 
addition, GM-CSF and G-CSF prolonged 
survival and expanded lifespan of cells in 
blastic stage in the culture, only during the 
first week of cultivation after which they re-
verted back to homeostasis. This finding 
might be the effect of GM-CSF in regulating 
the expansion and maturation of primitive 
hematopoietic progenitors (Barreda et al., 
2004; Lin et al., 1989). Ultimately, these 
CD34+ cells serve as the only source of pro-
genitor cells for the in vitro development of 
hematopoietic cells. 
In this study, we used defined cytokine 
combinations as the minimal culture sup-
plements to prevent the development of any 
particular cell lineage of HSC, allowing us to 
observe the unbiased differentiation of HSC 
in vitro. Various immune cell types includ-
ing T cells, B cells, monocytes, NK cells, 
NKT cells and DC cells, were obtained un-
der these conditions. The results indicated 
that CD34+ HSC from cord blood had the 
ability to produce both lymphoid and mye-
loid lineages in vitro. The in vitro production 
of these two lineages is of great interest in 
the understanding of immune-biology due to 
the unique primary responsiveness (consider-
ing their naïve status) of these in vitro pro-
duced mononuclear cells. However, 40-50 % 
of the remaining cells found in both culture 
conditions were polymorph nuclear (PMN), 
making them the major population of WBC 
as determined by Giemsa staining (data not 
shown).  
The number of monocytes and NK cells 
formed in the in vitro cultures were similar 
to the levels found in peripheral blood (Table 
2). This indicates that the regulation of pro-
liferation and differentiation of HSC in these 
culture conditions was functioning to control 
cell growth. This is supported by the notion 
that the combination of external signals from 
the bone marrow microenvironment (Can, 
2008) and internal factors like transcription 
factor could strongly influence the develop-
ment pattern of the hematopoietic stem cells. 
B cells and NKT cells had greater numbers 
of cells than PB, showing that these culture 
 = PBMC,  = HSC-derived MNCs 
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conditions support the differentiation of 
these cells. In addition T cells (CD3+ cells) 
and dendritic cells had lower number of cells 
than PB, probably because T cells and den-
dritic cells need other factors such as IL-2 
and IL-4, respectively. These cytokines are 
required for growth and survival and are ca-
pable of inducing cell proliferation (Bach-
mann and Oxenius, 2007). 
HSC-derived T lymphocytes in these cul-
ture conditions responded to PHA stimula-
tion. This suggested that the derived T lym-
phocytes had the ability to be directly re-
sponsive to mitogens. T lymphocytes derived 
from HSC required a longer exposure time 
and higher concentration of PHA to induced 
mitogenic stimulation than that needed for 
peripheral blood T lymphocytes. The need 
for longer exposure at higher concentrations 
for the in vitro produced lymphocytes may 
be associated with the immaturity of the T 
cells, since PHA is a potent stimulator of 
mature T cells (Webb et al., 1973; Stone et 
al., 2009). In addition, a high lectin binding 
sites on the CD34+ stem cells were recently 
identified by flow cytometry and light mi-
croscopy (Kuemmel et al., 1997). PHA may 
have absorbed to CD34+ cells leading to the 
need for a greater PHA concentration to acti-
vate T lymphocytes. 
In summary, GM-CSF and G-CSF have 
the ability to prolong the survival of the ex-
panding population of HSC-derived MNCs 
and to maintain the survival of cells in 
blastic stage. This is the first report showing 
the complete differentiation and proliferation 
of immune cells derived from CD34+ HSC 
under in vitro culture conditions. HSC-
derived MNCs were capable of responding 
tomitogen. Lymphocytes, monocytes, den-
dritic cells and polymorph nuclear cells de-
rived from HSC in vitro are unique and thus 
may benefit various studies such as innate 
immunity and models of immune disorders. 
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